Stay updated with breaking news from Product Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
Boulder, Colo. (PRWEB) May 04, 2022 -- Enterprise Management Associates (EMA), a leading IT and data management research and consulting firm, today announced
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on diagnostic products addressing Tuberculosis infections. Detailed information about the review process and submission requirements can be found in the document below.
The Global Fund is inviting manufacturers of COVID-19 pharmaceutical products (namely Molnupiravir 200mg capsules for oral administration) to submit an expression of interest to have their product evaluated by the Expert Review Panel for Pharmaceutical Products.
During the ongoing COVID-19 pandemic, the Center for Devices and Radiological Health (CDRH) in the U.S. Food and Drug Administration (FDA or the Agency) issued a series of Emergency Use...